GB1257162A - - Google Patents
Info
- Publication number
- GB1257162A GB1257162A GB1257162DA GB1257162A GB 1257162 A GB1257162 A GB 1257162A GB 1257162D A GB1257162D A GB 1257162DA GB 1257162 A GB1257162 A GB 1257162A
- Authority
- GB
- United Kingdom
- Prior art keywords
- bis
- chain
- group
- substituted
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1,257,162. Bis-chromones and intermediates. FISONS PHARMACEUTICALS Ltd. 31 Jan., 1969 [16 Feb., 1968 (2)], Nos. 7587/69 and 7589/68. Heading C2C. In a process for preparing compounds (I) and its function derivatives. wherein the pairs A 1 and A 2 on one benzene ring may be the same or different from the pairs A 1 and A 2 on the other benzene ring and each pair is OM and H on -COJ; H and -OCD= CHCOOR<SP>2</SP>; OCOCOR<SP>11</SP> and H or -COCH 3 ; or A 1 and A 2 together form the chains -CO-CH=C(D)-O- or -COCH 2 -CH(D)-O- (where M is H, an alk. metal cation or a lower alkyl group; J is a group CH 3 , OR<SP>2</SP>, CH 2 COD or CH=CHD, R<SP>2</SP> is H or 1-10 C alkyl, D is COOR<SP>2</SP> or a group V convertible thereto and R<SP>11</SP> is OH or a group convertible thereto); X is a carbocyclic or heterocyclic ring, straight or branched, saturated or unsaturated, substituted or unsubstituted hydrocarbon chain which chain may be interrupted by one or more heterocyclic or carbocyclic rings, carbonyl groups, 0, S, substituted S, NH, or substituted NH; P, Q, P<SP>1</SP> and Q<SP>1</SP> may be the same or different and may be H, halogen, alkyl, alkoxy, substituted alkyl or alkoxy, the groups T and T<SP>1</SP> are removed from compounds (II) where T and T<SP>1</SP> are the same or different and are carboxylic or sulphonic acid groups or their functional derivatives, tert.-butyl, allyl or an alpha-unsaturated alkyl group, a protected amino group, halogen, nitro or cyano. Furthermore the process includes the step of converting A 1 and A 2 in compounds where one or neither of the pairs A 1 and A 2 form a chain -CO-CH=C(COOH)-O- or a derivative thereof, into such a chain. T and T<SP>1</SP> may be removed by decarboxylation, treatment with strong acids, hydrolysis and diazotization, heating with steam or water, reduction and diazotization and hydrolysis and decarboxylation according to the value of T and T<SP>1</SP>. A 1 and A 2 may be condensed to form a chain by reaction with a dehydrating agent. The following intermediates are prepared: 1,5 - bis - (3 - hydroxy - 4 - methoxycarbonylphenoxy) pentane, and 1,5-bis-(4-carboxy-3-hydroxyphenoxy) pentane; 1,3-bis-(2-acetyl-3-hydroxy - 6 - iodophenoxy) - 2 - hydroxy propane and 1,3 - bis - (2 - ethoxycarbonyl - 6 - iodochromon - 5 - yloxy) - 2 - hydroxy propane.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB758768 | 1968-02-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1257162A true GB1257162A (en) | 1971-12-15 |
Family
ID=9835993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1257162D Expired GB1257162A (en) | 1968-02-16 | 1968-02-16 |
Country Status (2)
Country | Link |
---|---|
AT (1) | AT305981B (en) |
GB (1) | GB1257162A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2391618A2 (en) * | 2009-01-29 | 2011-12-07 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US9855276B2 (en) | 2012-10-25 | 2018-01-02 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US9925282B2 (en) | 2009-01-29 | 2018-03-27 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10058530B2 (en) | 2012-10-25 | 2018-08-28 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US10188757B2 (en) | 2013-10-22 | 2019-01-29 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10525005B2 (en) | 2013-05-23 | 2020-01-07 | The General Hospital Corporation | Cromolyn compositions and methods thereof |
US10561612B2 (en) | 2017-07-20 | 2020-02-18 | The General Hospital Corporation | Powdered formulations of cromolyn sodium and ibuprofen |
US11291648B2 (en) | 2018-07-02 | 2022-04-05 | The General Hospital Corporation | Powdered formulations of cromolyn sodium and alpha-lactose |
US11679095B2 (en) | 2016-08-31 | 2023-06-20 | The General Hospital Corporation | Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases |
-
1968
- 1968-02-16 GB GB1257162D patent/GB1257162A/en not_active Expired
-
1969
- 1969-02-11 AT AT514471A patent/AT305981B/en active
Cited By (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10245331B2 (en) | 2009-01-29 | 2019-04-02 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
CN102341391A (en) * | 2009-01-29 | 2012-02-01 | 通用医疗公司 | Cromolyn derivatives and related methods of imaging and treatment |
EP2391618A4 (en) * | 2009-01-29 | 2012-07-18 | Gen Hospital Corp | Cromolyn derivatives and related methods of imaging and treatment |
US8617517B2 (en) | 2009-01-29 | 2013-12-31 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
AU2010208136B2 (en) * | 2009-01-29 | 2015-03-05 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
CN102341391B (en) * | 2009-01-29 | 2015-08-19 | 通用医疗公司 | Cromoglycic Acid derivative and the application be prepared in the medicine of picture and treatment |
CN105061376A (en) * | 2009-01-29 | 2015-11-18 | 通用医疗公司 | Cromolyn derivatives and related methods of imaging and treatment |
EP2391618A2 (en) * | 2009-01-29 | 2011-12-07 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US11801316B2 (en) | 2009-01-29 | 2023-10-31 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10576171B2 (en) | 2009-01-29 | 2020-03-03 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US9925282B2 (en) | 2009-01-29 | 2018-03-27 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
EP3567033A1 (en) * | 2009-01-29 | 2019-11-13 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10251961B2 (en) | 2009-01-29 | 2019-04-09 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US9855276B2 (en) | 2012-10-25 | 2018-01-02 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US9918992B2 (en) | 2012-10-25 | 2018-03-20 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US10058530B2 (en) | 2012-10-25 | 2018-08-28 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US10398704B2 (en) | 2012-10-25 | 2019-09-03 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US10406164B2 (en) | 2012-10-25 | 2019-09-10 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US10413551B2 (en) | 2012-10-25 | 2019-09-17 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer'S disease and related disorders |
US9968618B1 (en) | 2012-10-25 | 2018-05-15 | The General Hospital Corporation | Combination therapies for the treatment of Alzheimer's disease and related disorders |
US9913847B2 (en) | 2012-10-25 | 2018-03-13 | The General Hospital Corporation | Combination therapies for the treatment of alzheimer's disease and related disorders |
US11110097B2 (en) | 2012-10-25 | 2021-09-07 | The General Hospital Corporation | Combination therapies for the treatment of alzheimer's disease and related disorders |
US10525005B2 (en) | 2013-05-23 | 2020-01-07 | The General Hospital Corporation | Cromolyn compositions and methods thereof |
US11013686B2 (en) | 2013-05-23 | 2021-05-25 | The General Hospital Corporation | Cromolyn compositions and methods thereof |
US11666669B2 (en) | 2013-10-22 | 2023-06-06 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US10188757B2 (en) | 2013-10-22 | 2019-01-29 | The General Hospital Corporation | Cromolyn derivatives and related methods of imaging and treatment |
US11679095B2 (en) | 2016-08-31 | 2023-06-20 | The General Hospital Corporation | Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases |
US10561612B2 (en) | 2017-07-20 | 2020-02-18 | The General Hospital Corporation | Powdered formulations of cromolyn sodium and ibuprofen |
US11291648B2 (en) | 2018-07-02 | 2022-04-05 | The General Hospital Corporation | Powdered formulations of cromolyn sodium and alpha-lactose |
Also Published As
Publication number | Publication date |
---|---|
AT305981B (en) | 1973-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1257162A (en) | ||
ES424859A1 (en) | Process for the manufacture of 2-arylamino-2-imidazoline derivatives and their salts | |
GB1436089A (en) | Process for the preparation of furylbenzimidazoles | |
GB1037378A (en) | Improved method for the preparation of substituted oxazole compounds | |
GB1430221A (en) | Process for recovering resorcinol and hydroquinone in mixture | |
GB1512919A (en) | Process for isolating triarylmethane dyestuffs | |
IT1058547B (en) | Dehydro-linalol cyclisation using polyphosphoric acid - prods. being useful as perfume (intermediates) | |
Erlanger et al. | Phosphorus Pentaoxide as a Reagent in Peptide Synthesis | |
GB1497217A (en) | Process for the preparation of cyanuric acid | |
GB1536320A (en) | Process for the mono-diazotization of aromatic diamines | |
GB1308055A (en) | Process for the preparation of nitroximes and nitroketones | |
GB1195273A (en) | Tolan Derivatives and manufacture and use thereof | |
GB1323157A (en) | Waterinsoluble dyestuffs and process for their manufacture | |
GB1389227A (en) | Chromone-2-carboxylic acid derivatives methods for their preparation and compositions containing them | |
GB1491772A (en) | Method for purifying 11-cyano-undecanoic acid | |
GB1256288A (en) | Process for recovering methyl methacrylate | |
GB1204121A (en) | Novel bis-chromonyl compounds, their preparation and use | |
GB1476341A (en) | 5-oxohexane-nitrile | |
GB1425309A (en) | Process for the preparation of 5-nitro-1,4-naphthoquinone | |
GB1463706A (en) | Process for recovering purified 4-hydroxy-2,4,6-trimethyl-2,5- cyclohexadien-1-on | |
GB1228521A (en) | ||
GB1262607A (en) | PROCESS FOR THE MANUFACTURE OF beta-ACETOXYPIVALIC ALDEHYDE | |
Baliah et al. | Preparation of 1-Methylsulfonyl-4-phenyl-1, 3-butadiene | |
SU498294A1 (en) | Method for preparing macroheterocyclic compounds | |
GB1242786A (en) | THE PREPARATION OF gamma-LACTONES FROM OLEFINS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLNP | Patent lapsed through nonpayment of renewal fees |